Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2005; 11(21): 3304-3306
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3304
Table 1 Primers for amplification and their nucleotide sequences.
PrimersNucleotide sequence
Uppernt15791-158105'-ATCATTGGACAAGTAGCATC-3’
Downnt725-7065'-GGTGAACTCACTGGAACGGG-3’
Table 2 Primers for sequencing and their nucleotide sequences.
PrimersNucleotide sequence
Uppernt111-nt1305'-ACCCTATGTCGCAGTATCTG-3’
Uppernt16328-163475'-CGTACATAGCACATTACAGT-3’
Downnt16540-165145'-GTGGGCTATTTAGGCTTTATGACCCTG-3’
Table 3 Mutations in D-loop region of mitochondrial DNA in gastric cancer.
LocationCambridge sequenceCancer nucleotideNormal tissue nucleotide
16122TCT
16221CTC
16234CDeletionC
16366TCT
16401CAC
16438GAG
16465AGA
16492ADeletionA
16494CTC
41CTC
72TCT
167CGC
255GAG
303(C)7(C)8(C)7
303(C)7(C)9(C)8
392TCT
514(CA)5(CA)6(CA)5
567(C)6(C)7(C)6
Table 4 ROS level and cell cycle in mutation group and control group (mean±SD).
ROS (MFI)Apoptosis (%)G0/G1 (%)S (%)G2/M (%)
Mutation group n = 7156.3±9.7a12.5±1.5a57.3±5.322.3±2.4a20.6±2.1
Control group n = 13117.3±10.48.6±0.165.4±5.616.4±1.518.1±1.3